Papier de conférence
Henin, G., Declerck, S., Goffaux, A., André-Dumont, S., Baldin, P., Starkel, P., & Lanthier, N. (2025). Ballooning degeneration and fibrosis are responsible for high liver stiffness in human alcohol-related liver disease. ESBRA, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Lanthier, N. (2025). Nutrition intervention studies in liver cirrhosis-associated sarcopenia. 47th ESPEN congress on clinical nutrition and metabolism, Prague.
Declerck, S., Lanthier, N., & Dahlqvist, G. (2025). La sarcopénie, présente chez les patients cirrhotiques avec une dénutrition modérée à sévère est associée à une densité accrue du tissu adipeux. Revue Médicale de Bruxelles, 46(2), 147. (Original work published 2025)
Prado Gonzalez, V., Debray, D., Poujois, A., & Lanthier, N. (2025). Nouveautés dans la maladie de Wilson. Séminaire maladie de Wilson, Luxembourg.
Lanthier, N. (2025). Metabolic steatohepatitis, gut microbiota and skeletal muscle changes: three pieces of the same risky puzzle? From results to new projects. LDRI Seminar, Brussels.
Deswysen, Y., Danse, E., Trefois, P., Van den Eynde, M., & Lanthier, N. (2025). High prevalence of myopenia and myosteatosis in patients with oesophagogastric cancer. Clinical Nutrition ESPEN, 69(October 2025), 829. https://doi.org/10.1016/j.clnesp.2025.07.042 (Original work published 2025)
Lanthier, N. (2025). Les maladies stéatosiques du foie: nouvelle nomenclature, diagnostic et évolution. Congrès d’hépato-gastroentérologie, Bruxelles.
Deswysen, Y., Danse, E., Trefois, P., Van den Eynde, M., & Lanthier, N. (2025). Oesophagogastric cancers are associated with high rates of myopenia and myosteatosis. Belgian Nutrition Society, Brussels.
Lanthier, N. (2025). Metabolic dysfunction-associated steatotic liver disease: non-invasive tests for diagnosis and prognosis. BASL Wintermeeting 2025, Antwerpen.
Lanthier, N. (2025). L’importance du ratio cuivre échangeable/cuivre total (REC) dans le diagnostic de la maladie de Wilson: rationnel et cas cliniques exemplatifs. Séminaire de biologie clinique, Brussels.
Lanthier, N. (2025). Towards comprehensive, general care: the example of steatotic liver disease. Annual Symposium of the Belgian Nutrition Society, Brussels.
Lanthier, N. (2025). Lessons to learn from the gut microbiome: a liver disease perspective. ESE 2025 Programme Book, 82.
Terken, C., André-Dumont, S., Henin, G., Orioli, L., Loumaye, A., & Lanthier, N. (2025). Discordance entre la prévalence de la sarcopénie selon les critères diagnostiques chez les patients présentant un diabète de type 2. Revue Médicale de Bruxelles, 46(2), 145. (Original work published 2025)
Lanthier, N. (2025). After ESPEN 2025. After ESPEN 2025, ’s Hertogenbosch, Netherlands.
Lanthier, N. (2025). Gastro-intestinal problems and physical exercise. 37th Belgian Week of Gastroenterology, Le Palais des Congrès, Liège.
André-Dumont, S., Scholtens, J., & Lanthier, N. (2025). Bénéfice du dépistage de l’élasticité hépatique dans la perte de poids des patients atteints d’une maladie hépatique stéatosique métabolique. Revue Médicale de Bruxelles, 46(2), 146. (Original work published 2025)
Henin, G., Goffaux, A., André-Dumont, S., Pendeville, E., Valet, M., Lejeune, T., Dahlqvist, G., Loumaye, A., Starkel, P., & Lanthier, N. (2025). Muscle function is already impaired in non-cirrhotic patients with steatotic liver disease compared to healthy controls. Acta Gastro-Enterologica Belgica, 88(1), A03. (Original work published 2025)
Article de journal
Lefere, S., Troisi, R. I., Karam, V., Fondevila, C., Nevens, F., Verbeek, J., Detry, O., Lanthier, N., Serenari, M., Wiering, L., Vanwolleghem, T., Moreno, C., Berrevoet, F., & Geerts, A. (2025). The Clinical Relevance of Prior Metabolic and Bariatric Surgery in Alcohol-Related Liver Disease in a Nationwide Belgian Liver Transplant Population. Liver international : official journal of the International Association for the Study of the Liver, 45(1), e16219. https://doi.org/10.1111/liv.16219 (Original work published 2025)
Lanthier, N., Baldin, P., & Starkel, P. (2025). Let’s take a look at drinks, but also at solid foods. Acta Gastro-Enterologica Belgica, 88(4), 375-376. https://doi.org/10.51821/88.4.14463 (Original work published 2025)
Lejeune, A., Starkel, P., Louvet, A., Hittelet, A., Bazille, C., Bastens, B., Orlent, H., Lasser, L., Dekoninck, X., Dastis, S. N., Delwaide, J., Geerts, A., Moreno, C., Galocsy, C. d., Putzeys, V., Langlet, P., Reynaert, H., Francque, S., Komuta, M., & Lanthier, N. (2025). Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis. Translational Gastroenterology and Hepatology, 10(3), 1-16. https://doi.org/10.21037/tgh-24-92 (Original work published 2025)
Terken, C., Anzevui, A., Loumaye, A., & Lanthier, N. (2025). Nouveautés en nutrition clinique. Louvain médical, 144(5), 12-15. (Original work published 2025)
Lanthier, N., & Spahr, L. (2025). Macrophage therapy and liver regeneration: Results and perspectives. Clinics and Research in Hepatology and Gastroenterology, 49(4), 102569. https://doi.org/10.1016/j.clinre.2025.102569 (Original work published 2025)
Orioli, L., Lanthier, N., Loumaye, A., & Thissen, J.-P. (2025). L’obésité sarcopénique : un phénotype particulier de l’obésité ? Medi-Sphère, 791, 24-29. (Original work published 2025)
Deswysen, Y., Van den Eynde, M., & Lanthier, N. (2025). Myosteatosis in Oesophagogastric Cancer: A Systematic Review. Journal of cancer science and clinical therapeutics, 9(3), 112. https://doi.org/10.26502/jcsct.5079271 (Original work published 2025)
Kirk, F. T., Rewitz, K. S., Mariño, Z., Couchonnal, E., Lanthier, N., Papenthin, W., Berenguer, M., Poujois, A., Debray, D., Ala, A., García-Villarreal, L., Pop, T. L., Denk, G., Socha, P., & Sandahl, T. D. (2025). Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group. Orphanet Journal of Rare Diseases, 20(1), 573. https://doi.org/10.1186/s13023-025-04103-6 (Original work published 2025)
Lanthier, N. (2025). Dynamic imaging of macrophages in MASLD: A major interest in insulin resistance and outside the liver. JHEP Reports, 7(5), 101352. https://doi.org/10.1016/j.jhepr.2025.101352 (Original work published 2025)
Lanthier, N. (2025). Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis? Clinics and Research in Hepatology and Gastroenterology, 49(7), 102640. https://doi.org/10.1016/j.clinre.2025.102640 (Original work published 2025)
Lanthier, N., & Piessevaux, H. (2025). Editorial. Louvain médical, 144(1), 1. (Original work published 2025)
Dumont, C., Iesari, S., Baldin, P., Aydin, S., Henin, G., Philippart, M., Bonaccorsi Riani, E., Ciccarelli, O., Coubeau, L., Piessevaux, H., Lanthier, N., & Dahlqvist, G. (2025). Early diagnosis of liver graft steatosis and fibrosis: are non-invasive tests the answer? Translational Gastroenterology and Hepatology, 10, 51 [1-13]. https://doi.org/10.21037/tgh-24-131 (Original work published 2025)
Lanthier, N. (2025). Les maladies stéatosiques du foie : nouvelle nomenclature, diagnostic et évolution. Louvain médical, 144(1), 2-8. (Original work published 2025)
Orioli, L., Lanthier, N., Loumaye, A., & Thissen, J.-P. (2025). Is sarcopene obesitas een specifiek type van obesitas ? Medi-Sfeer, 791, 24-29. (Original work published 2025)
Stahl, K., Nalbant, B., Pape, T., Breteau, I., Coirier, V., Cardoso, F. S., de Haan, J., Janik, M. K., Wasmuth, J.-C., Madaleno, J., Merle, U., Frohme, J., Tepasse, P.-R., Müller, M., Große, K., Linke, A., Mareljic, N., Larsen, F. S., Dahlqvist, G., et al. (2025). Therapeutic plasma exchange in amatoxin associated acute liver failure–results from the multi-center Amanita-PEX study. Critical Care, 29(1), 458. https://doi.org/10.1186/s13054-025-05560-y (Original work published 2025)
Dahlqvist, G., Deprez, P., & Lanthier, N. (2025). EUS-guided portal pressure measurement: Beware of thrombosis risk. Journal of Hepatology, 83(2), e79-e80. https://doi.org/10.1016/j.jhep.2025.02.042 (Original work published 2025)
Lanthier, N. (2025). Innovations 2024 en Hépato-Gastroentérologie - MASH et resmetirom. Louvain médical, 144(2), 70-71. (Original work published 2025)
Henin, G., Goffaux, A., Declerck, S., André-Dumont, S., Pendeville, E., Valet, M., Lejeune, T., Dahlqvist, G., Loumaye, A., Schnabl, B., Starkel, P., & Lanthier, N. (2025). Non‐Cirrhotic Steatotic Liver Disease is Associated With Impaired Muscle Function: A Cross‐Sectional Study. JCSM Communications, 8(2), 1-11. https://doi.org/10.1002/rco2.70012 (Original work published 2025)
Lanthier, N., Annet, L., & Borbath, I. (2025). Innovations 2024 en hépato-gastroentérologie - Nouvelles recommandations concernant le carcinome hépatocellulaire. Louvain médical, 144(2), 72-74. (Original work published 2025)
Delire, B., Lanthier, N., Dahlqvist, G., Deprez, P., Moreels, T., Borbath, I., Annet, L., & Horsmans, Y. (2025). Innovations 2024 en Hépato-Gastroentérologie. Louvain médical, 144(2), 67-74. (Original work published 2025)
Papier de conférence
Declerck, S., Henin, G., André-Dumont, S., Goffaux, A., Baldin, P., Henry, P., Loumaye, A., Starkel, P., & Lanthier, N. (2024). Nutrition et maladie stéatosique du foie : pas d’évidence d’un impact de la consommation d’aliments ultra-transformés sur la sévérité de l’atteinte hépatique. Livre des résumés, symposium de nutrition clinique 2024, p. 10.
Scholtens, J., André-Dumont, S., Henin, G., Dahlqvist, G., & Lanthier, N. (2024). Liver elasticity evolution in metabolic dysfunction-associated steatotic liver disease patients: a real-life prospective study. Acta Gastro-Enterologica Belgica, 87(1), A33. (Original work published 2024)
Lanthier, N. (2024). Le microbiome intestinal dans la maladie stéatosique métabolique du foie: quels résultats ? quels liens vers les maladies bucco-dentaires ? Colloque de dentisterie de l’Université de Genève, Geneva, Switzerland.
Lanthier, N., & Orioli, L. (2024). Le dépistage de la MASLD en pratique courante en diabétologie: recommandations et nouveautés. Séminaire d’endocrinologie-hépatologie, Bruxelles.
Lanthier, N. (2024). La stéatohépatite métabolique. Journée de la Gastroentérologie (Société Luxembourgeoise de Gastroentérologie), Luxembourg.
Lanthier, N. (2024). La stéatose hépatique. 18e congrès UCL d’Endocrino-Diabétologie, Brussels, Belgium.
Lanthier, N., & Bozadjieva-Kramer, N. (2024). Bile acids in digestive physio(patho)logy. IREC seminar, Brussels.
Declerck, S., Henin, G., André-Dumont, S., Goffaux, A., Dahlqvist, G., Loumaye, A., Pendeville, E., Lejeune, T., Valet, M., & Lanthier, N. (2024). Frailty in MASLD patients is associated with the presence of diabetes and the degree of liver fibrosis. Acta Gastro-Enterologica Belgica, 87(1), A24. (Original work published 2024)
Boliaki, N., Henin, G., & Lanthier, N. (2024). Impact of peroxisome proliferator-activated receptor agonists on myosteatosis in the context of metabolic dysfunction-associated steatotic liver disease. Acta Gastro-Enterologica Belgica, 87(1), A01. (Original work published 2024)
Lanthier, N. (2024). MASH et resmetirom. Livre des résumés, Société Royale Belge de Gastro-Entérologie, Actualités, 2024, p. 30-31.
Lanthier, N., Poujois, A., & Stephenne, X. (2024). La maladie de Wilson: quoi de neuf ? Séminaire Wilson, La Hulpe.
Denos, C., Nain, C. W., Pachikian, B., Hdidou, S., Rasse, C., Dierge, E., Debier, C., Trefois, P., Larondelle, Y., & Lanthier, N. (2024). Création de crackers enrichis en acides gras polyinsaturés avec des bénéfices pour les paramètres métaboliques : un essai contrôlé randomisé en double aveugle chez des sujets en surpoids. Livre des résumés, symposium de nutrition clinique 2024, p. 9.
Dénos, C., Pachikian, C., Hdidou, S., Dierge, E., Debier, C., Trefois, P., Larondelle, Y., & Lanthier, N. (2024). Creation of snacks enriched with polyunsaturated fatty acids and benefits for metabolic parameters: a double-blind randomised controlled trial in overweight subjects. Acta Gastro-Enterologica Belgica, 87(1), A20. (Original work published 2024)
Declerck, S., Henin, G., Andre-Dumont, S., Goffaux, A., Loumaye, A., Baldin, P., Starkel, P., & Lanthier, N. (2024). Exploring the impact of dietary patterns and ultra-processed food consumption on the severity of biopsy-proven steatotic liver disease. Acta Gastro-Enterologica Belgica, 87(1), A03. (Original work published 2024)
Lanthier, N. (2024). Évaluation biologique des troubles hépatiques : dialogue entre le biologiste et le clinicien pour une prise en charge optimale. Les 24èmes journées marocaines de biologie clinique, Casablanca, Maroc.
Article de journal
Henin, G., Loumaye, A., Leclercq, I., & Lanthier, N. (2024). Myosteatosis: diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease. JHEP Reports, 6(2), 100963 [1-21]. https://doi.org/10.1016/j.jhepr.2023.100963 (Original work published 2024)
Boliaki, N., Henin, G., Bale, G. L., & Lanthier, N. (2024). Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease. Discovery medicine, 36(185), 1139-1153. https://doi.org/10.24976/discov.med.202436185.104 (Original work published 2024)
Bozadjieva-Kramer, N., Shin, J. H., Li, Z., Rupp, A. C., Miller, N., Kernodle, S., Lanthier, N., Henry, P., Seshadri, N., Myronovych, A., MacDougald, O. A., O’Rourke, R. W., Kohli, R., Burant, C. F., Rothberg, A. E., & Seeley, R. J. (2024). Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance. JCI Insight, 9(7), e174164 [1-21]. https://doi.org/10.1172/jci.insight.174164 (Original work published 2024)
Bale, G. L., Clarembeau, F., Starkel, P., Dahlqvist, G., Horsmans, Y., & Lanthier, N. (2024). Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clinics and Research in Hepatology and Gastroenterology, 48(8), 102428 [1-7]. https://doi.org/10.1016/j.clinre.2024.102428 (Original work published 2024)
Zorzi, G., Ngougni Pokem, P., Dahlqvist, G., Delire, B., Lanthier, N., Starkel, P., Horsmans, Y., Aupaix, C., Jnaoui, S., & Gruson, D. (2024). Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital. Diagnostics, 14(17), 1882 [1-13]. https://doi.org/10.3390/diagnostics14171882 (Original work published 2024)
Henin, G., & Lanthier, N. (2024). What references and what gold standard should be used to assess myosteatosis in chronic liver disease ? Journal of Hepatology, 81(6), e273-e274. https://doi.org/10.1016/j.jhep.2024.07.003 (Original work published 2024)
Dahlqvist, G., Dewit, O., Lanthier, N., & Starkel, P. (2024). Transplantation, MICI et stéatose hépatique : quelques nouveautés en 2023. Louvain médical, 143(02-03), 183-188. (Original work published 2024)
Borbath, I., Deprez, P., Dewit, O., Lanthier, N., Moreels, T., Starkel, P., & Piessevaux, H. (2024). In Memoriam: René Fiasse (1936-2024). Acta Gastro-Enterologica Belgica, 87(2), 346-347. https://doi.org/10.51821/87.2.13357 (Original work published 2024)
Fortunati, F., Froidure, A., Baldin, P., Horsmans, Y., Lanthier, N., Dahlqvist, G., & Delire, B. (2024). Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction. Therapeutic Advances in Drug Safety, 15, 1-10. https://doi.org/10.1177/20420986241270866 (Original work published 2024)
Haxhe, S., Baldin, P., Trefois, P., Havelange, V., & Lanthier, N. (2024). Jaundice with severe leucocytosis. Journal of Hepatology, 80(3), e103-e105. https://doi.org/10.1016/j.jhep.2023.10.014 (Original work published 2024)
Henin, G., Baldin, P., Frans, C., Havelange, V., Delire, B., Yombi, J. C., & Lanthier, N. (2024). Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest? Acta Gastro-Enterologica Belgica, 87(2), 344-345. https://doi.org/10.51821/87.2.13087 (Original work published 2024)
De Ledinghen, V., Furuhashi, M., Giannini, C., Chai, J., Xia, Z.-F., Jun, D. W., Li, G.-J., Treeprasertsuk, S., Li, Y.-X., Cheung, T. T., Zhang, F., Goh, G. B.-B., Seto, W.-K., Fouad, Y., Huang, H., Di Sessa, A., Li, Q.-H., Cholongitas, E., Zhang, L., et al. (2024). A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease. Hepatology International, 18(4), 1178-1201. https://doi.org/10.1007/s12072-024-10702-5 (Original work published 2024)
Lanthier, N. (2024). Stéatose hépatique : ce que l’endocrinologue doit savoir. Louvain médical, 143(04), 281-283. (Original work published 2024)
Henin, G., Loumaye, A., Deldicque, L., Leclercq, I., & Lanthier, N. (2024). Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease? Liver International, 44(8), 1781-1796. https://doi.org/10.1111/liv.15938 (Original work published 2024)
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., Anstee, Q. M., Abdelmalek, M. F., Younossi, Z., Baum, S. J., Francque, S., Charlton, M. R., Newsome, P. N., Lanthier, N., Schiefke, I., et al. (2024). A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine, 390(6), 497-509. https://doi.org/10.1056/nejmoa2309000 (Original work published 2024)
Papier de conférence
Raevens, S., Weichselbaum, L., Lanthier, N., & Nevens, F. (2023). Digital Post-AASLD 2022 educational Meeting. Digital post-AASLD meeting 2022, Online.
Lanthier, N. (2023). La sarcopénie en cas de cirrhose: évaluation, impact et prise en charge. Livre des résumés. Published. Actualités en gastro-entérologie (Société Royale Belge de Gastro-Entérologie), Namur.
Binet, Q., Loumaye, A., Hermans, M., & Lanthier, N. (2023). Benefits of systematic use of non-invasive fibrosis scores rather than fatty liver index in type 2 diabetes patients: a prospective study. Acta Gastro-Enterologica Belgica, 86(1), A20. (Original work published 2023)
Sansen, P.-Y., Hainaut, P., Baldin, P., Secco, L.-P., Vanlier, C., & Lanthier, N. (2023). Jaundice, fever and rash: when skin and liver histology give the diagnosis... BASL Winter meeting 2023, Mons.
Lanthier, N. (2023). Patholgie métabolique (insulinorésistance): la stéatohépatite métabolique. La revue Maghrébine d’Endocrinologie-Diabète et de Reproduction, 27(1), 22. (Original work published 2023)
Delorme, A., Goffaux, A., De Azevedo Coutinho Pereira, D., Dumont, C., Philippart, M., Henin, G., Braem, F., Dubois, E., Ciccarelli, O., Trefois, P., Lanthier, N., & Dahlqvist, G. (2023). Myosteatosis in the liver transplant candidate: Is it the future prognostic marker ? Acta Gastro-Enterologica Belgica, 86(1), A11. (Original work published 2023)
Henin, G., Baldin, P., Havelange, V., Delire, B., Yombi, J. C., & Lanthier, N. (2023). Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest ? BASL Winter meeting 2023, Mons.
Article de journal
Dolly, A., Pötgens, S., Thibaut, M., Neyrinck, A., de Castro, G. S., Galbert, C., Lefevre, C., Wyart, E., Gomes, S. P., Gonçalves, D. C., Lanthier, N., Baldin, P., Huot, J. R., Bonetto, A., Seelaender, M., Delzenne, N., Sokol, H., & Bindels, L. (2023). Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle, 14(3), 1569-1582. https://doi.org/10.1002/jcsm.13246 (Original work published 2023)
Lanthier, N. (2023). Sarcopenie bij cirrose. Ortho-Rheumato, 21(6), 28-32. (Original work published 2023)
Lanthier, N. (2023). La sarcopénie dans la cirrhose. Medi-Sphère, 739(Gastro News n°4), 12-17. (Original work published 2023)
Dumont, C., Lanthier, N., & Dahlqvist, G. (2023). Fibrosis and steatosis of the liver graft: are non-invasive tests useful? A short review. Clinics and Research in Hepatology and Gastroenterology, 47(8), 102194 [1-7]. https://doi.org/10.1016/j.clinre.2023.102194 (Original work published 2023)
Lanthier, N., & Armstrong, M. J. (2023). Metabolic steatosis: recent scientific data also support a change in nomenclature. Acta Gastro-Enterologica Belgica, 86(1), 105-106. https://doi.org/10.51821/86.1.11385 (Original work published 2023)
Bourseau, S., Bozadjieva-Kramer, N., Goffaux, A., Baldin, P., Etogo-Asse, F., Trefois, P., & Lanthier, N. (2023). Are elevated systemic bile acids involved in the pathophysiology of sarcopenia and liver injury following gastric bypass? Acta Gastro-Enterologica Belgica, 86(2), 377-381. https://doi.org/10.51821/86.2.11517 (Original work published 2023)
Lanthier, N. (2023). Sarcopenie bij cirrose. Medi-Sfeer, 739(Gastro News n°4), 12-17. (Original work published 2023)
Dahlqvist, G., Delire, B., Dewit, O., Lanthier, N., & Piessevaux, H. (2023). Innovations 2022 en hépato-gastroentérologie. Louvain médical, 142(2), 93-100. (Original work published 2023)
Declerck, S., Henin, G., & Lanthier, N. (2023). Alcohol Consumption and Skeletal Muscle: What We Know and What We Would Like to Know. Calcified Tissue International, 113(3), 354-356. https://doi.org/10.1007/s00223-023-01113-z (Original work published 2023)
Binet, Q., Loumaye, A., Hermans, M., & Lanthier, N. (2023). A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients. Journal of clinical and translational hepatology, 11(6), 1377-1386. https://doi.org/10.14218/jcth.2023.00117 (Original work published 2023)
Cardinale, V., Lanthier, N., Baptista, P. M., Carpino, G., Carnevale, G., Orlando, G., Angelico, R., Manzia, T. M., Schuppan, D., Pinzani, M., Alvaro, D., Ciccocioppo, R., & Uygun, B. E. (2023). Cell transplantation-based regenerative medicine in liver diseases. Stem cell reports, 18(8), 1555-1572. https://doi.org/10.1016/j.stemcr.2023.06.005 (Original work published 2023)
Lanthier, N. (2023). La sarcopénie dans la cirrhose. Ortho-Rhumato, 21(6), 28-32. (Original work published 2023)
Binet, Q., Hermans, M., & Lanthier, N. (2023). Screening for NAFLD and its severity in type 2 diabetic patients: value of magnetic resonance imaging and outstanding issues. Journal of Hepatology, 78(5), e166-e167. https://doi.org/10.1016/j.jhep.2022.12.004 (Original work published 2023)
Lanthier, N., Lefere, S., De Schepper, H., & Reenaers, C. (2023). Clinical nutrition, skeletal muscle and liver disease: linking the dots for good management. Acta Gastro-Enterologica Belgica, 86(2), 267-268. https://doi.org/10.51821/86.1.12052 (Original work published 2023)
Article de journal
Lanthier, N., & Vanuytsel, T. (2022). From the editor’s desk... Acta Gastro-Enterologica Belgica, 83(1), 3-4. (Original work published 2022)
Pichon, C., Nachit, M., Gillard, J., Vande Velde, G., Lanthier, N., & Leclercq, I. (2022). Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations. Frontiers in Nutrition, 9, 1051157 [1-15]. https://doi.org/10.3389/fnut.2022.1051157 (Original work published 2022)
Dumont, C., Wuestenberghs, F., Lanthier, N., Piessevaux, H., & Dahlqvist, G. (2022). Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome. Acta Gastro-Enterologica Belgica, 85(2), 311-319. https://doi.org/10.51821/85.2.9016 (Original work published 2022)
Lanthier, N., Delire, B., Dahlqvist, G., Denis, M. A., & Moreels, T. (2022). Innovations 2021 en hépato-gastro-entérologie. Louvain médical, 141(2), 78-84. (Original work published 2022)
Goffaux, A., Delorme, A., Dahlqvist, G., & Lanthier, N. (2022). Improving the prognosis before and after liver transplantation: Is muscle a game changer? World Journal of Gastroenterology, 28(40), 5807-5817. https://doi.org/10.3748/wjg.v28.i40.5807 (Original work published 2022)
Etienne, Q., Lebrun, V., Komuta, M., Navez, B., Thissen, J.-P., Leclercq, I., & Lanthier, N. (2022). Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis. Metabolites, 12(7), 625 [1-16]. https://doi.org/10.3390/metabo12070625 (Original work published 2022)
Ventura-Cots, M., Argemi, J., Jones, P. D., Lackner, C., El Hag, M., Abraldes, J. G., Alvarado, E., Clemente, A., Ravi, S., Alves, A., Alboraie, M., Altamirano, J., Barace, S., Bosques, F., Brown, R., Caballeria, J., Cabezas, J., Carvalhana, S., Cortez-Pinto, H., et al. (2022). Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. Gut, 71(9), 1856-1866. https://doi.org/10.1136/gutjnl-2021-324295 (Original work published 2022)
Lanthier, N., Lebrun, V., Molendi-Coste, O., van Rooijen, N., & Leclercq, I. (2022). Liver Fetuin-A at Initiation of Insulin Resistance. Metabolites, 12(11), 1023 [1-10]. https://doi.org/10.3390/metabo12111023 (Original work published 2022)
Vande Berg, P., Ulaj, A., de Broqueville, G., de Vos, M., Delire, B., Hainaut, P., Thissen, J.-P., Starkel, P., Komuta, M., Henry, P., & Lanthier, N. (2022). Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis. Obesity Surgery : including Laparoscopy and Allied Care, 32(4), 1227-1235. https://doi.org/10.1007/s11695-022-05930-3 (Original work published 2022)
Lanthier, N., Ruiz Moreno, A., Dahlqvist, G., Delire, B., Starkel, P., & Horsmans, Y. (2022). Results of a screening campaign for hepatitis C viral infection in a Brussels hospital : do we need to go further? Acta Gastro-Enterologica Belgica, 82(2), 338. (Original work published 2022)
Lanthier, N., & Delzenne, N. (2022). Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time? Cells, 11(17), 2718 [1-17]. https://doi.org/10.3390/cells11172718 (Original work published 2022)
Lanthier, N., & Spahr, L. (2022). Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis. Alimentary Pharmacology and Therapeutics, 55(7), 889-890. https://doi.org/10.1111/apt.16835 (Original work published 2022)
Henin, G., Lanthier, N., & Dahlqvist, G. (2022). Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target? Acta Gastro-Enterologica Belgica, 85(4), 611-624. https://doi.org/10.51821/85.4.10899 (Original work published 2022)
Binet, Q., Annet, L., Danse, E., Goffette, P., & Lanthier, N. (2022). Hepatobiliary and Pancreatic: An uncommon cause of portal hypertension. Journal of gastroenterology and hepatology, 37(10), 1843. https://doi.org/10.1111/jgh.15961 (Original work published 2022)
Méndez-Sánchez, N., Bugianesi, E., Gish, R. G., Lammert, F., Tilg, H., Nguyen, M. H., Sarin, S. K., Fabrellas, N., Zelber-Sagi, S., Fan, J.-G., Shiha, G., Targher, G., Zheng, M.-H., Chan, W.-K., Vinker, S., Kawaguchi, T., Castera, L., Yilmaz, Y., Korenjak, M., et al. (2022). Global multi-stakeholder endorsement of the MAFLD definition. The lancet. Gastroenterology & hepatology, 7(5), 388-390. https://doi.org/10.1016/S2468-1253(22)00062-0 (Original work published 2022)
Maccioni, L., Loriot, A., Dewulf, J., Bommer, G., Horsmans, Y., Lanthier, N., Leclercq, I., Schnabl, B., & Starkel, P. (2022). Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans. Alimentary Pharmacology and Therapeutics, 56(6), 1055-1070. https://doi.org/10.1111/apt.17177 (Original work published 2022)
Rodriguez, J., Neyrinck, A., Van Kerckhoven, M., Gianfrancesco, M. A., Renguet, E., Bertrand, L., Cani, P., Lanthier, N., Cnop, M., Paquot, N., Thissen, J.-P., Bindels, L., & Delzenne, N. (2022). Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals. BMC Medicine, 20(1), 110 [1-20]. https://doi.org/10.1186/s12916-022-02299-z (Original work published 2022)
André-Dumont, S., & Lanthier, N. (2022). Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ? Nutrition Clinique et Métabolisme, 36(1), 12-20. https://doi.org/10.1016/j.nupar.2021.11.001 (Original work published 2022)
Clerbaux, L.-A., Mayasich, S. A., Muñoz, A., Soares, H., Petrillo, M., Albertini, M. C., Lanthier, N., Grenga, L., & Amorim, M.-J. (2022). Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. Journal of Clinical Medicine, 11(19), 5691 [1-23]. https://doi.org/10.3390/jcm11195691 (Original work published 2022)
Binet, Q., Loumaye, A., Preumont, V., Thissen, J.-P., Hermans, M., & Lanthier, N. (2022). Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ? Acta Gastro-Enterologica Belgica, 85(2), 346-357. https://doi.org/10.51821/85.2.9775 (Original work published 2022)
Lanthier, N., Delire, B., Dahlqvist, G., Denis, M. A., & Moreels, T. (2022). Hépatologie, endoscopie et proctologie: quelques faits marquants en 2021. Louvain médical, 141(2), 78-84. (Original work published 2022)
Papier de conférence
Lanthier, N. (2022). Alcool, stéatose et microbiote. Livre des résumés. Published. Société Royale Belge de Gastroentérologie (SRBGE), Namur.
Lanthier, N., Degroote, H., & Vanwolleghem, T. (2022). Digital post-EASL educational meeting 2022. Digital post-EASL educational meeting 2022, Online.
Dumont, C., Iesari, S., Lanthier, N., Henin, G., Bonaccorsi Riani, E., Ciccarelli, O., Coubeau, L., Baldin, P., Aydin, S., & Dahlqvist, G. (2022). Assessment of a transient elastography in predicting the graft fibrosis after liver transplantation and validation of the Venturi score in an adult population. Acta Gastro-Enterologica Belgica, 85(1), A20. (Original work published 2022)
Lanthier, N. (2022). Microbiote intestinal et foie. Journée de formation continue de l’ASMA (Association Scientifique de Médecine d’Assurance), Bruxelles.
Lanthier, N. (2022). Malnutrition and liver disease: assessement and implementation of nutritional therapy. Belgian Association for the Study of the Liver (BASL) Winter Meeting & Liver Course, Wallonia Conference Center Mons (WCCM).
Lanthier, N. (2022). Cibler le microbiome intestinal pour traiter la maladie stéatosique du foie liée à une dysfonction métabolique (MAFLD): preuves et résultats. NutriFacts, Oct-Nov-Dec(4), 20-24. (Original work published 2022)
Lanthier, N. (2022). Why should the clinician be interested in sekeletal muscle? IREC seminar, Brussels.
Papier de conférence
Lanthier, N., Vande Berg, P., Vande Berg, A., Harkemanne, E., Peeters, C., & Havelange, V. (2021). How skin and liver can lead to diagnosis. Belgian Association for the Study of the Liver (BASL) liver meeting, Mons.
Lanthier, N. (2021). The role of gut microbiota. EASL NAFLD summit 2021, Digital.
Lanthier, N. (2021). La stéatohépatite non-alcoolique (NASH): définition, diagnostic et prise en charge thérapeutique. Innovation contre le syndrome métabolique, Charleroi.
Salavrakos, M., de Timary, P., Ruiz Moreno, A., Thissen, J.-P., & Lanthier, N. (2021). The importance of personalised care in metabolic dysfunction-associated fatty liver disease. Belgian Association for the Study of the Liver (BASL) liver meeting, Mons.
Vande Berg, P., Ulaj, A., de Broqueville, G., de Vos, M., Delire, B., Hainaut, P., Thissen, J.-P., Starkel, P., Henry, P., Komuta, M., & Lanthier, N. (2021). Acute liver decompensation following bariatric surgery in patients without cirrhosis: clinical presentation, histological findings and management. Acta Gastro-Enterologica Belgica, 84(1), A09. (Original work published 2021)
Lanthier, N. (2021). La stéatohépatite non-alcoolique. Société de Médecine de Charleroi, Charleroi.
Lanthier, N. (2021). The gut microbiota in metabolic dysfunction-associated fatty liver disease. Conference book. Published. Liver-gut axis worshop, Falk symposium, German Association for the Study of the Liver (GASL), Münster.
Article de journal
Leyrolle, Q., Cserjesi, R., Mulders, M. D. G. H., Zamariola, G., Hiel, S., Gianfrancesco, M. A., Rodriguez, J., Portheault, D., Amadieu, C., Leclercq, S., Bindels, L., Neyrinck, A., Cani, P., Karkkainen, O., Haninheva, K., Lanthier, N., Trefois, P., Paquot, N., Cnop, M., et al. (2021). Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients. Clinical Nutrition, 40, 2035-2044. https://doi.org/10.1016/j.clnu.2020.09.025 (Original work published 2021)
Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Trefois, P., Neyrinck, A., Cani, P., Bindels, L., Thissen, J.-P., & Delzenne, N. (2021). Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Scientific Reports, 11(1), 659 [1-14]. https://doi.org/10.1038/s41598-020-79718-9 (Original work published 2021)
Baldin, P., Van den Eynde, M., Mlecnik, B., Bindea, G., Beniuga, G., Carrasco, J., Haicheur, N., Marliot, F., Lafontaine, L., Fredriksen, T., Lanthier, N., Hubert, C., Navez, B., Huyghe, N., Pagès, F., Mourin, A., Galon, J., & Komuta, M. (2021). Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore. Journal of Pathology: Clinical Research, 7(1), 27-41. https://doi.org/10.1002/cjp2.178 (Original work published 2021)
Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., Lanthier, N., Alkhouri, N., Moreno, C., Schattenberg, J. M., Stefanova-Petrova, D., Vonghia, L., Rouzier, R., Guillaume, M., Hodge, A., et al. (2021). A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. New England Journal of Medicine, 385(17), 1547-1558. https://doi.org/10.1056/nejmoa2036205 (Original work published 2021)
Lanthier, N., Starkel, P., & Dahlqvist, G. (2021). Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity? Clinics and Research in Hepatology and Gastroenterology, 45(4), 101721 [1-2]. https://doi.org/10.1016/j.clinre.2021.101721 (Original work published 2021)
Lanthier, N. (2021). La maladie stéatosique du foie liée à une dysfonction métabolique : enfin une nomenclature plus claire avec des critères diagnostiques positifs. Louvain médical, 140(02), 109. (Original work published 2021)
Vande Berg, P., Vande Berg, A., Harkemanne, E., Peeters, C., Havelange, V., & Lanthier, N. (2021). How skin and liver can lead to diagnosis. Acta Gastro-Enterologica Belgica, 84(4), 682-683. https://doi.org/10.51821/84.4.024 (Original work published 2021)
Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Trefois, P., Neyrinck, A., Cani, P., Bindels, L., Thissen, J.-P., & Delzenne, N. (2021). Publisher Correction: Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Scientific Reports, 11(1), 6123. https://doi.org/10.1038/s41598-021-85083-y (Original work published 2021)
Lanthier, N. (2021). Le lanifibranor, un activateur des trois isoformes de PPAR, entraîne une régression de l’inflammation et de la fibrose hépatique dans la NASH ainsi que des effets métaboliques bénéfiques. Louvain médical, 140(02), 110. (Original work published 2021)
Spahr, L., Lanthier, N., Tihy, M., Frossard, J.-L., Rubbia-Brandt, L., & Goossens, N. (2021). Clinical presentation and gene expression of acute alcohol-induced microvesicular steatosis mimicking alcoholic hepatitis. Hepatology Communications, 5(4), 618-628. https://doi.org/10.1002/hep4.1669 (Original work published 2021)
Vande Berg, P., Borbath, I., Baldin, P., Vande Berg, D., Hainaut, P., & Lanthier, N. (2021). Granuloma formation within perihepatic lymphadenopathy. Clinics and Research in Hepatology and Gastroenterology, 45(6), 101504 [1-4]. https://doi.org/10.1016/j.clinre.2020.07.009 (Original work published 2021)
Lanthier, N., Borbath, I., Dahlqvist, G., Delire, B., & Dewit, O. (2021). Stéatose métabolique, carcinome hépatocellulaire, prurit cholestatique, encéphalopathie et maladies inflammatoires intestinales: quelles nouveautés en 2020? Louvain médical, 140(2), 108-115. (Original work published 2021)
Lanthier, N., Starkel, P., & Dahlqvist, G. (2021). Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible? Clinics and Research in Hepatology and Gastroenterology, 45(2), 101661 [1-3]. https://doi.org/10.1016/j.clinre.2021.101661 (Original work published 2021)
Vanuytsel, T., & Lanthier, N. (2021). The growing impact of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 84(1), 1-2. (Original work published 2021)
Nachit, M., Lanthier, N., Rodriguez, J., Neyrinck, A., Cani, P., Bindels, L., Hiel, S., Pachikian, B. D., Trefois, P., Thissen, J.-P., & Delzenne, N. (2021). A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients. JHEP Reports, 3(4), 100323 [1-10]. https://doi.org/10.1016/j.jhepr.2021.100323 (Original work published 2021)
Leyrolle, Q., Cserjesi, R., D.G.H. Mulders, M., Zamariola, G., Hiel, S., Gianfrancesco, M. A., Portheault, D., Amadieu, C., Bindels, L., Leclercq, S., Rodriguez, J., Neyrinck, A., Cani, P., Lanthier, N., Trefois, P., Bindelle, J., Paquot, N., Cnop, M., Thissen, J.-P., et al. (2021). Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: a randomized, controlled trial. Brain, Behavior, and Immunity, 94(May), 289-298. https://doi.org/10.1016/j.bbi.2021.01.014 (Original work published 2021)
Hamoir, C., Horsmans, Y., Starkel, P., Dahlqvist, G., Negrin Dastis, S., & Lanthier, N. (2021). Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents. Acta Gastro-Enterologica Belgica, 84(1), 25-32. https://doi.org/10.51821/84.1.420 (Original work published 2021)
Knudsen, C., Neyrinck, A., Leyrolle, Q., Baldin, P., Leclercq, S., Rodriguez, J., Beaumont, M., Cani, P., Bindels, L., Lanthier, N., & Delzenne, N. (2021). Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice. The Journal of Nutrition, 151(6), 1507-1516. https://doi.org/10.1093/jn/nxab032 (Original work published 2021)
Lanthier, N., Mahiat, C., Henrard, S., Starkel, P., Gilard, I., De Brauwer, I., Cornette, P., & Boland, B. (2021). Gastro-intestinal symptoms are associated with a lower in-hospital mortality rate in frail older patients hospitalized for COVID-19. Acta Gastro-Enterologica Belgica, 84(1), 135-136. https://doi.org/10.51821/84.1.824 (Original work published 2021)
Salavrakos, M., de Timary, P., Moreno, A., Thissen, J.-P., & Lanthier, N. (2021). Fructoholism in adults: the importance of personalised care in metabolic dysfunction-associated fatty liver disease. JHEP Reports, 4(1), 100396 [1-2]. https://doi.org/10.1016/j.jhepr.2021.100396 (Original work published 2021)
Article de journal
Lanthier, N., & Tim Vanuytsel. (2020). For better visibility of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 83(2), 243-244. (Original work published 2020)
Lanthier, N., & Vanuytsel, T. (2020). The changing landscape of hepatology and gastroenterology. Acta Gastro-Enterologica Belgica, 83(3), 371-372. (Original work published 2020)
Lanthier, N., & Vanuytsel, T. (2020). Metabolic dysfunction-associated fatty liver disease: a new clearer nomenclature with positive diagnostic criteria. Acta Gastro-Enterologica Belgica, 83(4), 513-515. (Original work published 2020)
Hiel, S., Gianfrancesco, M. A., Rodriguez, J., Portheault, D., Leyrolle, Q., Bindels, L., Gomes da Silveira Cauduro, C., Mulders, M. D. G. H., Zamariola, G., Azzi, A.-S., Kalala, G., Pachikian, B. D., Amadieu, C., Neyrinck, A., Loumaye, A., Cani, P., Lanthier, N., Trefois, P., Klein, O., et al. (2020). Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial. Clinical Nutrition, 39(12), 3618-3628. https://doi.org/10.1016/j.clnu.2020.04.005 (Original work published 2020)
Rodriguez, J., Hiel, S., Neyrinck, A., Le Roy, T., Pötgens, S., Leyrolle, Q., Pachikian, B. D., Gianfrancesco, M. A., Cani, P., Paquot, N., Cnop, M., Lanthier, N., Thissen, J.-P., Bindels, L., & Delzenne, N. (2020). Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut, 69(11), 1975-1987. https://doi.org/10.1136/gutjnl-2019-319726 (Original work published 2020)
Dahlqvist, G., Delire, B., Dewit, O., Coubeau, L., Horsmans, Y., Lanthier, N., & Moreels, T. (2020). 2019 innovations in hepato-gastroenterology and hepatic transplantation surgery. Louvain médical, 139(02), 106-113. (Original work published 2020)
Lanthier, N., & Horsmans, Y. (2020). L’acide obéticholique comme traitement pharmacologique pour les patients atteints de stéatohépatite non-alcoolique fibrosante: des résultats intermédiaires prometteurs. Louvain médical, 139(02), 107. (Original work published 2020)
Lanthier, N. (2020). Physiopathologie de la NASH : de nouveaux facteurs de risque identifiés ? Louvain médical, 139(7), 405-410. (Original work published 2020)
Delire, B., Komuta, M., Michaux, L., & Lanthier, N. (2020). A rare cause of high liver stiffness. Acta Gastro-Enterologica Belgica, 83(4), 675-676. (Original work published 2020)
Clarembeau, F., Bale, G. L., & Lanthier, N. (2020). Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments. Clinical science (London, England : 1979), 134(16), 2117-2135. https://doi.org/10.1042/CS20200022 (Original work published 2020)
Lanthier, N., & Francque, S. (2020). NASH : a welfare disease with emerging questions and adequate answer attempts. Acta Gastro-Enterologica Belgica, 83(2), 339. (Original work published 2020)
Lanthier, N. (2020). Les nouveaux traitements de la stéatohépatite non-alcoolique. Nutrition Clinique et Métabolisme, 34(3), 216-222. https://doi.org/10.1016/j.nupar.2020.04.003 (Original work published 2020)
Mahiat, C., Henrard, S., Gilard, I., Lanthier, N., Starkel, P., De Brauwer, I., Cornette, P., & Boland, B. (2020). COVID-19 : présentation clinique et mortalité des 50 premiers patients gériatriques hospitalisés aux Cliniques universitaires Saint-Luc au printemps 2020. Louvain médical, 139 (09-10), 503-511. (Original work published 2020)
Papier de conférence
Lamotte, A., Leclercq, I., & Lanthier, N. (2020). The mechanisms of steatosis pathogenesis during NASH development. Acta Gastro-Enterologica Belgica, 83(1). (Original work published 2020)
Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Trefois, P., Bindels, L., Neyrinck, A., Cani, P., Thissen, J.-P., & Delzenne, N. (2020). New determinants of liver steatosis and fibrosis in obese patients: results of a prospective clinical study. Clinical Nutrition ESPEN, 40, 438-439. https://doi.org/10.1016/j.clnesp.2020.09.104 (Original work published 2020)
Francque, S., Bedossa, P., Ratziu, V., Anstee, Q., Bugianesi, E., Sanyal, A., Loomba, R., Harrison, S. A., Balabanska, R. I., Mateva, L., Lanthier, N., & et al. (2020). The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial. Hepatology, 72(1), 9A-11A. (Original work published 2020)
Lanthier, N. (2020). General medical management of variceal bleeding and endoscopic definitions of portal hypertension related lesions. BSGIE annual meeting 2020, Brussels.
Article de journal
Lanthier, N., & Spahr, L. (2019). Resident liver progenitor cells: Proofs of their contribution to human liver regeneration. Clinics and Research in Hepatology and Gastroenterology, 43(6), 646-648. https://doi.org/10.1016/j.clinre.2019.02.006 (Original work published 2019)
Ulpiano Trillig, A., Ramoisiaux, L., Komuta, M., & Lanthier, N. (2019). Autoimmune hepatitis in a patient with thymectomy: the benefit of histology and MUM-1 immunostaining. Acta Gastro-Enterologica Belgica, 82(4), 550-551. (Original work published 2019)
Starkel, P., Schnabl, B., Leclercq, S., Komuta, M., Bataller, R., Argemi, J., Palma, E., Chokshi, S., Hellerbrand, C., Maccioni, L., Lanthier, N., & Leclercq, I. (2019). Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis. Hepatology Communications, 3(7), 867-882. https://doi.org/10.1002/hep4.1364 (Original work published 2019)
Muyldermans, G., Bielen, R., Botterman, R., Bourgeois, S., Colle, I., Deressa, B., Devolder, G., Horsmans, Y., Hutse, V., Lanthier, N., Lasser, L., Platteau, S., Robaeys, G., Suin, V., Verhelst, X., Van Vlierberghe, H., & Van Baelen, L. (2019). Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis. Acta Gastro-Enterologica Belgica, 82(4), 479-485. (Original work published 2019)
Mahfouz, E., & Lanthier, N. (2019). Acute pancreatitis and obesity: where is the problem? Acta Gastro-Enterologica Belgica, 82(1), 104. (Original work published 2019)
Salavrakos, M., Piessevaux, H., Komuta, M., Lanthier, N., & Starkel, P. (2019). Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients. Journal of Clinical Gastroenterology, 53(10), 772-778. https://doi.org/10.1097/MCG.0000000000001119 (Original work published 2019)
Knudsen, C., Neyrinck, A., Lanthier, N., & Delzenne, N. (2019). Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? Current Opinion in Clinical Nutrition and Metabolic Care, 22(5), 393-400. https://doi.org/10.1097/MCO.0000000000000584 (Original work published 2019)
Clarembeau, F., Komuta, M., Horsmans, Y., & Lanthier, N. (2019). Impact of liver inflammation on whole body insulin resistance : a case report on primary biliary cholangitis. Acta Gastro-Enterologica Belgica, 82(4), 536-538. (Original work published 2019)
Lanthier, N., Ruiz-Moreno, A., Dahlqvist, G., Delire, B., Starkel, P., & Horsmans, Y. (2019). Results of a screening campaign for hepatitis C viral infection in a Brussels hospital : do we need to go further? Acta Gastro-Enterologica Belgica, 82(2), 338. (Original work published 2019)
Moreels, T., Fiasse, R., & Lanthier, N. (2019). The history of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 82(1), 57-61. (Original work published 2019)
Lanthier, N., & Moreels, T. (2019). The future of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 82(1), 3-4. (Original work published 2019)
Papier de conférence
Lanthier, N. (2019). NASH: quelles armes face à l’épidémie? Journée du Président, Société Royale Belge de Gastro-Entérologie (SRBGE), Namur.
Lanthier, N. (2019). Percutaneous gastrostomy and jejunostomy: indications, techniques and follow-up. Belgian Week of Gastroenterology (BWGE) Postgraduate course, Antwerpen.
Lanthier, N. (2019). La nutrition du patient cirrhotique: quels bénéfices? Entretiens de Nutrition Clinique, Hargimont.
Spahr, L., Lanthier, N., Rubbia-Brandt, L., & Goossens, N. (2019). Clinical presentation and transcriptome analysis of acute alcohol-induced microvesicular steatosis mimicking alcoholic steatohepatitis. Hepatology, 70(1), 174A. (Original work published 2019)
Lanthier, N. (2019). Nouveaux traitements dans la NASH. Journées Francophones de Nutrition (JFN) 2019, Rennes.
Lejeune, A., Starkel, P., Louvet, A., Hittelet, A., Bazille, C., Bastens, B., Orlent, H., Lasser, L., Dekoninck, X., Negrin Dastis, S., Delwaide, J., Geerts, A., de Galocsy, C., Putzeys, V., Langlet, P., Reynaert, H., Francque, S., Komuta, M., & Lanthier, N. (2019). New concepts in liver regeneration mechanisms in human severe alcoholic steatohepatitis. Acta Gastro-Enterologica Belgica, 82(1), A12. (Original work published 2019)
Papier de conférence
Lanthier, N. (2018). La NASH: de nouveaux facteurs protecteurs? Entretiens de Nutrition Clinique, Hargimont.
Rodriguez, J., Neyrinck, A., Le Roy, T., Leclercq, S., Hiel, S., Cani, P., Lanthier, N., Thissen, J.-P., Bindels, L., & Delzenne, N. (2018). Implication of the gut microbiota in personalized metabolic response to dietary inulin in obese patients. Clinical Nutrition, 37(Suppl 1), S148. https://doi.org/10.1016/j.clnu.2018.06.1548 (Original work published 2018)
Lanthier, N. (2018). Le bilan somatique du patient alcoolique: un outil d’interrogation et/ou de motivation? Forum Addiction et Société, Bruxelles.
Lanthier, N. (2018). The role of the liver in insulin resistance: focus on hepatic macrophages and fetuin-A. Louvain Drug Research Institute (LDRI) seminar, Brussels.
Etienne, Q., & Lanthier, N. (2018). Fetuin-A is secreted by hepatocytes rather than adipocytes during NAFLD-NASH development in mice and humans and correlates with insulin resistance. Belgian Association for the Study of Obesity (BASO) free communications meeting, Antwerpen.
Article de journal
Restellini, S., Goossens, N., Clément, S., Lanthier, N., Negro, F., Rubbia-Brandt, L., & Spahr, L. (2018). Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease. World Journal of Hepatology, 10(1), 73-81. https://doi.org/10.4254/wjh.v10.i1.73 (Original work published 2018)
Lanthier, N. (2018). La NASH en 2018. Louvain médical, 137(5), 308-313. (Original work published 2018)
Lanthier, N. (2018). Haemopoietic stem cell therapy in cirrhosis: the end of the story? The Lancet Gastroenterology and Hepatology, 3, 3-5. https://doi.org/10.1016/S2468-1253(17)30359-X (Original work published 2018)
Francque, S., Lanthier, N., Verbeke, L., Reynaert, H., van Steenkiste, C., Vonghia, L., Kwanten, W. J., Weyler, J., Trépo, E., Cassiman, D., Smets, F., Komuta, M., Dirinck, E., Danse, E., Op de Beeck, B., van Creanenbroeck, E., Van Nieuwenhove, T., Hubens, G., Geerts, A., et al. (2018). The Belgian Association for Study of the Liver guidance document on the management of non-alcoholic fatty liver disease. Acta Gastro-Enterologica Belgica, 81(1), 55-81. (Original work published 2018)
Yildiz, H., Vandercam, B., Thissen, X., Komuta, M., Lanthier, N., Debiève, F., & Dahlqvist, G. (2018). Hepatitis during pregnancy: A case of hemophagocytic lymphohistiocytosis. Clinics and Research in Hepatology and Gastroenterology, 42(3), e49-e55. https://doi.org/10.1016/j.clinre.2017.10.007 (Original work published 2018)
Hamoir, C., de Vos, M., Clinckart, F., Nicaise, G., Komuta, M., & Lanthier, N. (2018). Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy. Journal of gastroenterology and hepatology, 33(10), 1695. https://doi.org/10.1111/jgh.14136 (Original work published 2018)
Moreels, T., & Lanthier, N. (2018). The quest for quality. Acta Gastro-Enterologica Belgica, 81(1), 3-4. (Original work published 2018)
Article de journal
Lanthier, N., Lin-Marq, N., Rubbia-Brandt, L., Clément, S., Goossens, N., & Spahr, L. (2017). Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns? Stem Cell Research & Therapy, 8(1), 88 [1-10]. https://doi.org/10.1186/s13287-017-0541-2 (Original work published 2017)
Lanthier, N., & Starkel, P. (2017). Treatment of severe alcoholic hepatitis: past, present and future. European Journal of Clinical Investigation, 47(7), 531-539. https://doi.org/10.1111/eci.12767 (Original work published 2017)
Papier de conférence
Lanthier, N., & Spahr, L. (2017). Autologous hematopoietic stem cell transplantation into the liver in alcoholic hepatitis: what is the impact on liver histology and gene expression patterns? Acta Gastro-Enterologica Belgica, 80(1), A03. (Original work published 2017)
Lanthier, N. (2017). Les nouveaux traitements dans la stéatohépatite non-alcoolique. Livre de résumé des présentations, 2, 29-32. (Original work published 2017)
Lanthier, N., Horsmans, Y., & Leclercq, I. (2017). Lipid, fetuin-A and macrophage zonation in high fat diet foz-foz mice with non-alcoholic steatohepatitis. Acta Gastro-Enterologica Belgica, 80(1), A07. (Original work published 2017)
Lanthier, N. (2017). How to diagnose NASH: invasive versus non-invasive techniques. Belgian Association for the Study of the Liver (BASL) winter meeting, Gent.
Article de journal
Lanthier, N., & Spahr, L. (2016). SPINK1, macrophages et cellules progénitrices du foie: de nouvelles pistes pour stimuler la régénération dans l’hépatite alcoolique? M/S : médecine sciences, 32(2), 149-152. https://doi.org/10.1051/medsci/20163202005 (Original work published 2016)
Sacré, A., Lanthier, N., Dano, H., Aydin, S., Leggenhager, D., Weber, A., Dekairelle, A.-F., De Cuyper, A., Gala, J.-L., Humblet, Y., Sempoux, C., & Van den Eynde, M. (2016). Regorafenib induced severe toxic hepatitis: characterization and discussion. Liver International, 36(11), 1590-1594. https://doi.org/10.1111/liv.13217 (Original work published 2016)
Van Leeuw, J.-B., Berra, E., Gu, Y., Petit, T., Lacroix, V., Lanthier, N., Van Hoof, M., Staessen, J. A., & Persu, A. (2016). Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension? Journal of Hypertension, 34(8), 1659-1661. https://doi.org/10.1097/HJH.0000000000000997 (Original work published 2016)
Papier de conférence
Lanthier, N. (2016). Treatment of acute alcoholic hepatitis. Falk Symposium 205: New Treatment Targets in Gut and Liver Diseases, Lucerne.
Wuestenberghs, F., Lanthier, N., & Dahlqvist, G. (2016). Impact of nutritional status on cirrhotic inpatients’ prognosis: a retrospective monocentric study. Acta Gastro-Enterologica Belgica, 79(1), A24. (Original work published 2016)
Papier de conférence
Lanthier, N. (2015). Les scores d’activité et leur impact sur la prise en charge des patients en hépatologie. Syllabus de la Société Royale Belge de Gastro-Entérologie. Published. Société Royale Belge de Gastro-Entérologie, La Hulpe.
Degré, D., & Moreno, C. (2015). Safety and efficacy of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: the Belgian experience. Acta Gastro-Enterologica Belgica (Multilingual Edition), 78(1), A03. (Original work published 2015)
Article de journal
Lanthier, N., Starkel, P., & Horsmans, Y. (2015). New imaging assisted methods for liver fibrosis quantification: is it really favorable to classical transient elastrography ? Journal of Hepatology, 63(3), 765-766. https://doi.org/10.1016/j.jhep.2015.04.027 (Original work published 2015)
Ngoma, P. d. J., Kabamba-Mukadi, B., Dahlqvist, G., Sempoux, C., Lanthier, N., Shindano, T., Van Den Neste, E., & Horsmans, Y. (2015). Occult HBV reactivation induced by ibrutinib treatment : a case report. Acta Gastro-Enterologica Belgica, 78(4), 424-426. (Original work published 2015)
Lanthier, N. (2015). Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how? World Journal of Hepatology, 7(19), 2184-2188. https://doi.org/10.4254/wjh.v7.i19.2184 (Original work published 2015)
Lanthier, N., Rubbia-Brandt, L., Lin-Marcq, N., Clément, S., Frossard, J.-L., Goossens, N., Hadengue, A., & Spahr, L. (2015). Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. Journal of Hepatology, 63(3), 609-621. https://doi.org/10.1016/j.jhep.2015.04.003 (Original work published 2015)
Poekes, L., Lanthier, N., & Leclercq, I. (2015). Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome. Clinical Science, 129(11), 933-949. https://doi.org/10.1042/CS20150339 (Original work published 2015)
Papier de conférence
Starkel, P., Lanthier, N., & Horsmans, Y. (2014). Activation of interferon and NF-kB pathways in early human alcoholic liver disease development. Acta Gastro-Enterologica Belgica, 77(1), A03. (Original work published 2014)
Article de journal
Lanthier, N. (2014). The role of the liver in insulin resistance. Treatment Strategies - Hepatology, 1(1), 89-95. (Original work published 2014)
Lanthier, N., & Leclercq, I. (2014). Adipose tissues as endocrine target organs. Bailliere’s Best Practice & Research: Clinical Gastroenterology, 28(4), 545-558. https://doi.org/10.1016/j.bpg.2014.07.002 (Original work published 2014)
Lanthier, N., & Leclercq, I. (2014). Liver and systemic insulin resistance. Hepatology, 60(3), 1113-1114. https://doi.org/10.1002/hep.27017 (Original work published 2014)
Article de journal
Lanthier, N., Rubbia-Brandt, L., & Spahr, L. (2013). Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases. Acta Gastro-Enterologica Belgica, 76(1), 3-9. (Original work published 2013)
Lebrun, V., Molendi-Coste, O., Lanthier, N., Sempoux, C., Cani, P., van Rooijen, N., Starkel, P., Horsmans, Y., & Leclercq, I. (2013). Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice. Clinical Science, 125(11), 501-511. https://doi.org/10.1042/CS20130064 (Original work published 2013)
Spahr, L., Chalandon, Y., Terraz, S., Kindler, V., Rubbia-Brandt, L., Frossard, J.-L., Breguet, R., Lanthier, N., Farina, A., Passweg, J., Becker, C. D., & Hadengue, A. (2013). Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One, 8(1), e53719. https://doi.org/10.1371/journal.pone.0053719 (Original work published 2013)
Papier de conférence
Lanthier, N., Lebrun, V., Molendi-Coste, O., & Leclercq, I. (2013). High fat induced insulin resistance: the emerging role of hepatokines. BASO Free communications meetings, UZ Brussels.
Lanthier, N., & Spahr, L. (2013). High liver expression of SPINK-1 is associated with progenitor cell and hepatocyte proliferation and determines MELD score improvement in decompensated alcoholic liver disease. Journal of Hepatology, 58(S1), S54. (Original work published 2013)
Lanthier, N., Terraz, S., Breguet, R., & Spahr, L. (2013). Computed tomography derived liver volume: a prognostic factor in decompensated alcoholic cirrhosis? Acta Gastro-Enterologica Belgica, 76(1), 12. (Original work published 2013)
Lanthier, N., & Leclercq, I. (2013). High fat induced insulin resistance: the emerging role of hepatokines. Acta Gastro-Enterologica Belgica, 76(1), A16. (Original work published 2013)
Lanthier, N., Rubbia-Brandt, L., Lin-Marq, N., Chalandon, Y., Frossard, J.-L., & Spahr, L. (2013). Liver cell proliferation determines MELD score improvement in decompensated alcoholic liver disease. Acta Gastro-Enterologica Belgica, 76(1), A11. (Original work published 2013)
Papier de conférence
Poekes, L., Lanthier, N., Farrell, G. C., Leclercq, I., & Legry, V. (2012). Role of inflammation and insulin resistance in a new model of NASH: the foz/foz mice. Acta Gastro-Enterologica Belgica (Multilingual Edition), 75(1), A11. (Original work published 2012)
Lanthier, N., Hadengue, A., & Spahr, L. (2012). Proliferative activity in CK7 positive cells and hepatocytes as well as macrophage expansion predict MELD score improvement in decompensated alcoholic liver disease (ALD). Swiss Medical Weekly, 142(Suppl 194), 4S. (Original work published 2012)
Lanthier, N., Rubbia-Brandt, L., Kindler, V., Hadengue, A., & Spahr, L. (2012). Differential hepatic gene expression profiles identify improvement in MELD score following decompensation in alcoholic liver disease. Hepatology, 56(S1), 982A. (Original work published 2012)
Lanthier, N., Rubbia-Brandt, L., Hadengue, A., & Spahr, L. (2012). Bone marrow mononuclear cell infusion into the liver is associated with liver macrophage expansion in patients with decompendated alcoholic liver disease (ALD). Swiss Medical Weekly, 142(Suppl 194), 14S. (Original work published 2012)
Lanthier, N., & Spahr, L. (2012). Fibrosis quantification in alcoholic liver disease: a histological-hemodynamic study. Swiss Medical Weekly, 142(Suppl 194), 14S. (Original work published 2012)
Article de journal
Cao, D. T., Reny, J.-L., Lanthier, N., & Frossard, J.-L. (2012). Intramural Hematoma of the Esophagus. Case Reports in Gastroenterology, 6(2), 510-517. https://doi.org/10.1159/000341808 (Original work published 2012)
Lanthier, N., Terraz, S., & Frossard, J.-L. (2012). An unusual cause of cholecystitis. Gastroenterology, 143(6), e9-e10. https://doi.org/10.1053/j.gastro.2012.07.010 (Original work published 2012)
Goossens, N., Ditisheim, S., Lanthier, N., Spahr, L., & Hadengue, A. (2012). Alcoholic steatohepatitis: what’s new in 2012? Revue Médicale Suisse, 8(352), 1646-1648. (Original work published 2012)
Article de journal
Van Hul, N., Lanthier, N., Espanol Suner, R., Abarca-Quinones, J., van Rooijen, N., & Leclercq, I. (2011). Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury. The American Journal of Pathology : cellular and molecular biology of disease, 179(4), 1839-1850. https://doi.org/10.1016/j.ajpath.2011.06.042 (Original work published 2011)
Lanthier, N., Molendi-Coste, O., Cani, P., van Rooijen, N., Horsmans, Y., & Leclercq, I. (2011). Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. The FASEB Journal, 25(12), 4301-4311. https://doi.org/10.1096/fj.11-189472 (Original work published 2011)
Papier de conférence
Lanthier, N., Molendi-Coste, O., Horsmans, Y., & Leclercq, I. (2011). Does TLR4 participate to the early activation of Kupffer cells elicited by a high fat diet ? Hepatology, 54(4), 1174A. (Original work published 2011)
Papier de conférence
Van Hul, N., Lanthier, N., & Leclercq, I. (2010). Liver progenitor cell expansion in the injured mouse liver: Do Kupffer cells play a role? Belgian Week of Gastroenterology Abstract Book, p. 12.
Lanthier, N., Molendi-Coste, O., Cani, P., Horsmans, Y., & Leclercq, I. (2010). Cross-talk between Kupffer cells and adipose tissue in the pathogenesis of insulin resistance. Hepatology, 52(5), 1045A. (Original work published 2010)
Article de journal
Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I., MacDougald, O. A., & Bommer, G. (2010). Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. Journal of Biological Chemistry, 285(44), 33652-33661. https://doi.org/10.1074/jbc.M110.152090 (Original work published 2010)
Lanthier, N., Molendi-Coste, O., Horsmans, Y., van Rooijen, N., Cani, P., & Leclercq, I. (2010). Kupffer cell activation is a causal factor for hepatic insulin resistance. American Journal of Physiology: Gastrointestinal and Liver Physiology, 298(1), G107-116. https://doi.org/10.1152/ajpgi.00391.2009 (Original work published 2010)
Papier de conférence
Lanthier, N., Petit, M., Pèlerin, H., Abarca-Quinones, J., Lebrun, V., Molendi-Coste, O., Campard, D., Horsmans, Y., & Leclercq, I. (2009). Kupffer cell depletion improves hepatic insulin sensitivity. Acta Gastro-Enterologica Belgica (Multilingual Edition), 72(1), A11. (Original work published 2009)
Lanthier, N., Horsmans, Y., Molendi-Coste, O., Lebrun, V., Petit, M., Cani, P., & Leclercq, I. (2009). Kupffer Cell Activation Participates in the Initiation of High Fat Diet-induced Hepatic Insulin Resistance. Hepatology, 50(4), 1177A-1177A. (Original work published 2009)
Lanthier, N., Molendi-Coste, O., Horsmans, Y., Cani, P., & Leclercq, I. (2009). Liver and adipose tissue macrophage depletion improves hepatic insulin sensitivity. Basic science workshop syllabus, p. 32.
Article de journal
Lanthier, N., & Leclercq, I. (2009). Adiponectin in non-alcoholic steatohepatitis: an ideal culprit, but what are the proofs of its guilt? Journal of gastroenterology and hepatology, 24(10), 1584-1586. https://doi.org/10.1111/j.1440-1746.2009.06087.x (Original work published 2009)
Lanthier, N., Horsmans, Y., & Leclercq, I. (2009). The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis. Current Opinion in Clinical Nutrition and Metabolic Care, 12(4), 404-411. https://doi.org/10.1097/MCO.0b013e32832c7819 (Original work published 2009)
Pierard, S., Coche, J.-C., Lanthier, P., Dekoninck, X., Lanthier, N., Rahier, J., & Geubel, A. (2009). Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. European Journal of Gastroenterology and Hepatology, 21(8), 941-945. https://doi.org/10.1097/MEG.0b013e3283155451 (Original work published 2009)
Lanthier, N., Horsmans, Y., & Leclercq, I. (2009). Clodronate liposomes: All sites of injection are not equal. Hepatology (Baltimore, Md.), 51(2), 721-2; author reply 722. https://doi.org/10.1002/hep.23455 (Original work published 2010)
Papier de conférence
Lanthier, N., Van Hul, N., Abarca-Quinones, J., Lebrun, V., Petit, M., Sempoux, C., Horsmans, Y., & Leclercq, I. (2008). High fat feeding induces hepatic insulin resistance and preferential distribution of Kupffer cells around lipid loaded hepatocytes. Gut, 57(10), A43. (Original work published 2008)
Lanthier, N., Van Hul, N., Abarca-Quinones, J., Lebrun, V., Sempoux, C., Horsmans, Y., & Leclercq, I. (2008). After short-term exposure of mice to a high fat diet, F4/80 positive macrophages are preferentially found in the vicinity of lipid-loaded hepatocytes. Acta Gastro-Enterologica Belgica, 71(1), A04. (Original work published 2008)
Papier de conférence
Kersten, V., Lanthier, N., Descamps, O., Semeria, S., Marcovitch, O., & de Meester, A. (2006). Clinical and echocardiographic data predict diagnosis in patients younger than 40 years admitted for chest pain and elevated troponin I levels. Acta Clinica Belgica, 61(5), 304. (Original work published 2006)
Article de journal
Lanthier, N., Parc, C., Scavennec, R., Dhôte, R., Brézin, A., Guillevin, L., & et al. (2005). Infliximab in the treatment of posterior uveitis in Behçet’s disease. Long term follow up in four patients. La Presse Médicale, 34(13), 916-918. https://doi.org/10.1016/S0755-4982(05)84079-5 (Original work published 2005)
Lanthier, N. (2005). Nouvelle perspective thérapeutique de l’insuffisance cardiaque. Louvain médical, 124(1), 39-44. (Original work published 2005)
